Clinical Trial Update: Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports on the safety and efficacy study of anakinra for post-acute COVID-19 syndrome, with Phase 2 and Phase 3 arms currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute COVID-19 Syndrome

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Hellenic Institute for the Study of Sepsis | Conditions: Post-Acute COVID-19 Syndrome, Post-Acute COVID-19 | Phase 2, Phase 3 | Status: RECRUITING